BioCorRx (BICX) Other Non Operating Income (2013 - 2026)

BioCorRx has disclosed Other Non Operating Income across 8 years of filings, most recently posting -$100000.0 for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$100000.0, down 268.24% year-over-year; the trailing twelve-month figure through Mar 2026 was -$155000.0 (down 343.47% YoY), and the FY2025 annual result was -$187514.0, down 245.04% from the prior year.
• Other Non Operating Income came in at -$100000.0 for Q1 2026 at BioCorRx, down from -$55000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $59439.0 in Q1 2025 to a low of -$198939.0 in Q3 2022.
• The 5-year median for Other Non Operating Income is -$540.0 (2024), against an average of -$31659.6.
• Across the five-year window, Other Non Operating Income plunged 101.36% in 2024 and slumped 268.24% in 2026, its largest moves.
• BioCorRx's Other Non Operating Income stood at -$198939.0 in 2022, then soared by 119.91% to $39613.0 in 2023, then slumped by 101.36% to -$540.0 in 2024, then plunged by 10085.19% to -$55000.0 in 2025, then slumped by 81.82% to -$100000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$100000.0 (Q1 2026), -$55000.0 (Q2 2025), and $59439.0 (Q1 2025), per Business Quant data.